Skip to Content
Merck
CN

Skip To

P2C100V01

Millipore

Pellicon® 2 Mini Ultrafiltration Module

filtration area 0.1 m2, NMWCO 100 kDa

Synonym(s):

Pellicon® 2 Mini Ultrafiltration Module PLCHK V 0.1 m2

Sign Into View Organizational & Contract Pricing

Select a Size

500 ML
CN¥5,120.84

CN¥5,120.84


Estimated to ship onJuly 28, 2025Details


Select a Size

Change View
500 ML
CN¥5,120.84

About This Item

UNSPSC Code:
23151806

CN¥5,120.84


Estimated to ship onJuly 28, 2025Details


Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

material

composite regenerated cellulose (CRC)
polypropylene screen
polyurethane adhesive

Quality Level

manufacturer/tradename

Pellicon®

parameter

3.5 bar max. transmembrane pressure (50 psig) at 30 °C
5-35 L/min recirculation rate at 0.4 bar (6 psi)

technique(s)

analytical sample preparation: suitable
protein purification: suitable

H

2.16 cm (0.85 in.)

L

21 cm (8.3 in.)

W

5.6 cm (2.2 in.)

filtration area

0.1 m2

membrane nominal area

0.1 m2

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
SCM003SCM082SCM017
technique(s)

cell culture | stem cell: suitable

technique(s)

cell culture | stem cell: suitable

technique(s)

cell culture | stem cell: suitable

technique(s)

cell culture | stem cell: suitable

form

liquid

form

liquid

form

liquid

form

liquid

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

Quality Level

100

Quality Level

300

Quality Level

300

Quality Level

100

manufacturer/tradename

Chemicon®

manufacturer/tradename

Chemicon®

manufacturer/tradename

-

manufacturer/tradename

Chemicon®

input

sample type neural stem cell(s)

input

sample type neural stem cell(s)

input

sample type induced pluripotent stem cell(s)
sample type: mouse embryonic stem cell(s)
sample type neural stem cell(s)

input

sample type neural stem cell(s)

General description

The Pellicon® 2 Ultrafiltration PLCHK Mini Cassette sets the standard in cassette-style tangential flow filtration devices. P2C100V01 was designed with process scale-up and applications development in mind.

Millipore′s PLCHK polyethersulfone membrane has void-free structures that guard against leakage of solutes through microdefects normally associated with voids beneath the thin skins of conventional UF membranes. These void-free membranes are more permeable, resulting in high-flux with equivalent or superior product retention. These void-free membranes provide the advantages of fast, high yield processing and smaller systems.

The Pellicon® 2 Mini Ultrafiltration Module feature a filtration area of 0.1 m2 with a pore size of 100 kDa NMWCO.

Application

Concentration, desalting or buffer exchange of:
  • Protein solutions
  • Polysaccharide solutions
  • Virus suspensions


Harvest, washing or clarification of:
  • Cell cultures and lysates
  • Colloidal suspensions
  • Viral cultures

Features and Benefits

  • Type V screen (open channel)
  • Leading-edge void- free membranes to match virtually any separation challenge
  • Short flow path for higher flux and higher resolution separation capability
  • Choice of flow channel configuration providing process optimization capability
  • Predictable, fast, scale-up
  • True linear scalability from laboratory size modules to industrial assemblies for processing thousands of liters
  • Brings higher resolution, improved yields and superior back-pressure resistance
  • Ultracel membranes are composite membranes cast on a microporous substrate for defect-free membranes with superior

Analysis Note

Gravimetric Extractables: after a water flush

Other Notes

Prefiltration Rquirements: 100 µm
These products are manufactured in a facility which adheres to FDA Good Manufacturing Practices.

Legal Information

Pellicon is a registered trademark of Merck KGaA, Darmstadt, Germany
ULTRACEL is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

10 - Combustible liquids

WGK

WGK 2


  • Certificates of Analysis (COA)

    Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Shumpei Yamada et al.
    International journal of cancer, 111(1), 17-22 (2004-06-09)
    Cyclin E and Cdk2 have been shown to play an important role in G1/S transition of the cell cycle. Two E-type cyclins (E1 and E2) have been identified to date and share functionally similarities. Upregulation of these cyclins has been
    Banumathi K Cole et al.
    Molecular and cellular biology, 28(4), 1274-1284 (2007-12-19)
    Merlin, the product of the NF2 tumor suppressor gene, is closely related to the ERM (ezrin, radixin, moesin) proteins, which provide anchorage between membrane proteins and the underlying cortical cytoskeleton; all four proteins are members of the band 4.1 superfamily.
    Marie-Noëlle Giraud et al.
    Journal of applied physiology (Bethesda, Md. : 1985), 99(1), 313-322 (2005-07-23)
    Neuregulin/ErbB2-induced kinase signaling provides essential survival and protection clues for functional integrity of the adult heart and skeletal muscle. To define the regulatory pathways involved in neuregulin-dependent muscle cell survival, we set out to map the largely unknown transcript targets
    Raanan Berger et al.
    Cancer research, 66(11), 5723-5728 (2006-06-03)
    The mechanisms underlying the progression of prostate cancer to a state of resistance to hormone ablation remain poorly understood. Here, we have investigated the relationship between androgen receptor (AR) and Her-2/neu in prostate cancer cells. Overexpression of Her-2/neu (c-ErbB2) activates
    Yanyuan Wu et al.
    Cancer research, 70(13), 5475-5485 (2010-06-17)
    Trastuzumab treatment has improved the overall survival of HER2-overexpressing breast cancer patients. However, many of these patients will eventually become resistant to treatment. The mechanisms that contribute to resistance to trastuzumab are unknown. In this study, we tested the hypothesis

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service